NCT05874869View on ClinicalTrials.gov

Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in Tanzania

NACompletedINTERVENTIONAL
Enrollment

13,800

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
MalariaChemoprophylaxisUnderfive Children
Interventions
DRUG

Dihydroartemisinin-piperaquine

The drug will be administered once a day for three consecutive days for three months (March, April, and May)

Trial Locations (1)

65001

Muhimbili University of Health and Allied Ssciences, Dar es Salaam

All Listed Sponsors
collaborator

Muhimbili University of Health and Allied Sciences

OTHER

collaborator

National Institute for Medical Research, Tanzania

OTHER_GOV

collaborator

Hubert Kairuki Memorial University

OTHER

lead

Richard Mwaiswelo

OTHER_GOV

NCT05874869 - Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in Tanzania | Biotech Hunter | Biotech Hunter